Updates in Medical Oncology

Monday, November 3, 2025, 9:00 AM - 4:30 PM, Dorrance H. Hamilton Building, Philadelphia, PA


AMA PRA Category 1 Credits™ (4.25 hours), AAPA Category 1 CME Credits (4.25 hours), ABS CC (4.25 hours), ACPE Contact Hour(s) (4.25 hours), ANCC Contact Hour(s) (4.25 hours), Non-Physician Attendance (4.25 hours)

Updates in Medical Oncology will provide a review of recent developments in the therapy of cancers and related diseases. Disease area experts will use a case-based approach to discuss the use of emerging therapies in the clinical arena, including a discussion of the practical aspects of therapy, supportive care, and therapy-related toxicities.

Attendees will have the opportunity to participate in disease area roundtable discussions on the current state of the art for specific malignancies, along with active clinical trials.

Keynote: Hoda J. Badr, PhD

Dr. Badr is a clinical psychologist and behavioral scientist whose clinical and research interests focus on enhancing the well-being of cancer patients and their families through evidence-based psychosocial and behavioral interventions. Her work lies at the intersection of psychology, oncology, behavioral medicine, and public health, with a strong focus on health equity and real-world impact.

A core area of her research involves psychosocial oncology, where she addresses the emotional and psychological challenges faced by cancer patients and their caregivers. She is particularly known for her work in developing dyadic interventions, which are programs designed to support both the patient and their partner or family member. These interventions aim to enhance communication, coping, and emotional support between couples dealing with cancer, improving outcomes for both parties.

She is also deeply committed to addressing health disparities in medically underserved populations, ensuring that interventions are adapted for use in low-resource or safety-net settings. Through her work in implementation science, she focuses on translating effective behavioral interventions into routine clinical care by engaging key stakeholders to ensure feasibility, sustainability, and cultural sensitivity.

Her interests extend into cancer survivorship and palliative care, with projects aimed at improving symptom management, quality of life, and end-of-life communication for patients with advanced disease. She also contributes broadly to behavioral medicine, particularly in the area of chronic disease self-management, helping patients adhere to treatment and adopt healthier lifestyle behaviors.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Sunday, November 22, 2025. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

---

This course is free and open to Jefferson Health enterprise oncology staff only.

1. Analyze recent advances in gastrointestinal malignancy treatments to determine their implications for patient management.
2. Evaluate the role of minimal residual disease testing in clinical oncology by integrating current evidence into clinical decision-making strategies.
3. Describe the use radiation oncology therapies for patients with oligometastatic disease by applying updated therapeutic approaches.
4. Formulate treatment plans for patients with multiple myeloma by implementing updated standards of care and integrating recent clinical trial data.
5. Summarize the use of tumor infiltrating lymphocyte therapy in patients with metastatic melanoma, including the potential benefits and toxicities.
6. Apply updated treatment paradigms for patients with GU malignancies, reflecting recent clinical trial advances.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 4.25 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 4.25 nursing contact hours.

Pharmacists: This knowledge-based continuing education is designated for 4.25 credit contact hours of continuing education credit. JA#
Credits will be uploaded to CPE Monitor within 60 days following the completion of the activity. This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner's e-profile in CPE Monitor.

Physicians Assistants:

 

Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Other Healthcare Professionals: This educational activity is designated for 4.25 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Agenda
Agenda subject to change without notice.

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Photography and Recording
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.

Copyright
All rights reserved – Thomas Jefferson University. No part of this program may be used, reproduced, or shared in any manner whatsoever without express written permission, except in the case of brief quotations embodied in articles or reviews.

Dorrance H. Hamilton Building
Thomas Jefferson University
1001 Locust St space 1021
Philadelphia, PA 19107

Directions

Parking

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Monday, November 3, 2025

This educational activity received no commercial support.

Exhibitor Rules

• Exhibitor is not providing commercial support for this educational activity. Exhibitor is purchasing exhibit space.

• Exhibits are intended for informational purposes; products should not be sold through the exhibit hall.

• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitute a payment or transfer of value to a covered participant, which is required to be reported under the Sunshine Act.

• Exhibitors may observe educational sessions but must refrain from participating in the activity.

• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

Application Deadline

Applications for exhibits will be accepted through Friday, October 13, 2025.  After October 13, 2025, applications may be accepted on a case by case basis.

Cancellation and Refunds

In the event that the symposium is canceled by the organizers, exhibit fees will be refunded in full, however Thomas Jefferson University is not responsible for other expenses incurred by the exhibitor.

In the event an exhibitor cancels participation, refunds will be made as follows:

Prior to the deadline of October 13, 2025 a refund will be given minus a 10% administration fee.

• After October 13, 2025 no refund will be given.

• Exhibitors who are absent from the conference will not receive a refund.

• Exhibit cancellations must be made in writing and confirmed received by Jefferson OCPD by October 13, 2025.

• Send cancellation notice to [email protected] and include name of activity in subject line.

Exhibit at this Event